RAF/RAS oncogenes and mismatch-repair status
Harith Rajagopalan,
Alberto Bardelli,
Christoph Lengauer,
Kenneth W. Kinzler,
Bert Vogelstein and
Victor E. Velculescu ()
Additional contact information
Harith Rajagopalan: Sidney Kimmel Comprehensive Cancer Center, Howard Hughes Medical Institute, and Program in Cellular and Molecular Medicine, Johns Hopkins University School of Medicine
Alberto Bardelli: Sidney Kimmel Comprehensive Cancer Center, Howard Hughes Medical Institute, and Program in Cellular and Molecular Medicine, Johns Hopkins University School of Medicine
Christoph Lengauer: Sidney Kimmel Comprehensive Cancer Center, Howard Hughes Medical Institute, and Program in Cellular and Molecular Medicine, Johns Hopkins University School of Medicine
Kenneth W. Kinzler: Sidney Kimmel Comprehensive Cancer Center, Howard Hughes Medical Institute, and Program in Cellular and Molecular Medicine, Johns Hopkins University School of Medicine
Bert Vogelstein: Sidney Kimmel Comprehensive Cancer Center, Howard Hughes Medical Institute, and Program in Cellular and Molecular Medicine, Johns Hopkins University School of Medicine
Victor E. Velculescu: Sidney Kimmel Comprehensive Cancer Center, Howard Hughes Medical Institute, and Program in Cellular and Molecular Medicine, Johns Hopkins University School of Medicine
Nature, 2002, vol. 418, issue 6901, 934-934
Abstract:
Abstract Genes of the RAF family encode kinases that are regulated by Ras and mediate cellular responses to growth signals. Activating mutations in one RAF gene, BRAF, have been found in a high proportion of melanomas and in a small fraction of other cancers1. Here we show that BRAF mutations in colorectal cancers occur only in tumours that do not carry mutations in a RAS gene known as KRAS, and that BRAF mutation is linked to the proficiency of these tumours in repairing mismatched bases in DNA. Our results not only provide genetic support for the idea that mutations in BRAF and KRAS exert equivalent effects in tumorigenesis2, but also emphasize the role of repair processes in establishing the mutation spectra that underpin human cancer.
Date: 2002
References: Add references at CitEc
Citations:
Downloads: (external link)
https://www.nature.com/articles/418934a Abstract (text/html)
Access to the full text of the articles in this series is restricted.
Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.
Export reference: BibTeX
RIS (EndNote, ProCite, RefMan)
HTML/Text
Persistent link: https://EconPapers.repec.org/RePEc:nat:nature:v:418:y:2002:i:6901:d:10.1038_418934a
Ordering information: This journal article can be ordered from
https://www.nature.com/
DOI: 10.1038/418934a
Access Statistics for this article
Nature is currently edited by Magdalena Skipper
More articles in Nature from Nature
Bibliographic data for series maintained by Sonal Shukla () and Springer Nature Abstracting and Indexing ().